Placental stem cell correction of murine intermediate maple syrup urine disease
Open Access
- 23 November 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 57 (3), 1017-1023
- https://doi.org/10.1002/hep.26150
Abstract
There is improved survival and partial metabolic correction of a mouse intermediate maple syrup urine disease (iMSUD) model after allogenic hepatocyte transplantation, confirming that a small number of enzyme-proficient liver-engrafted cells can improve phenotype. However, clinical shortages of suitable livers for hepatocyte isolation indicate a need for alternative cell sources. Human amnion epithelial cells (hAECs) share stem cell characteristics without the latter's safety and ethical concerns and differentiate to hepatocyte-like cells. Eight direct hepatic hAEC transplantations were performed in iMSUD mice over the first 35 days beginning at birth; animals were provided a normal protein diet and sacrificed at 35 and 100 days. Treatment at the neonatal stage is clinically relevant for MSUD and may offer a donor cell engraftment advantage. Survival was significantly extended and body weight was normalized in iMSUD mice receiving hAEC transplantations compared with untreated iMSUD mice, which were severely cachectic and died ≤28 days after birth. Branched chain α-keto acid dehydrogenase enzyme activity was significantly increased in transplanted livers. The branched chain amino acids leucine, isoleucine, valine, and alloisoleucine were significantly improved in serum and brain, as were other large neutral amino acids. Conclusion: Placental-derived stem cell transplantation lengthened survival and corrected many amino acid imbalances in a mouse model of iMSUD. This highlights the potential for their use as a viable alternative clinical therapy for MSUD and other liver-based metabolic diseases. (HEPATOLOGY 2013)Keywords
This publication has 43 references indexed in Scilit:
- Amniotic membrane: from structure and functions to clinical applicationsCell and tissue research, 2012
- Transplantation Tolerance Induced in Humans at the Fetal or the Neonatal StageJournal of Transplantation, 2011
- Hepatic differentiation of amniotic epithelial cellsHepatology, 2011
- Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in MousePLOS ONE, 2011
- Leucine and α-Ketoisocaproic Acid, but Not Norleucine, Stimulate Skeletal Muscle Protein Synthesis in Neonatal Pigs , ,Journal of Nutrition, 2010
- Branched-chain Amino Acid MetabolonPublished by Elsevier BV ,2010
- Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Hepatocyte Transplantation Improves Phenotype and Extends Survival in a Murine Model of Intermediate Maple Syrup Urine DiseaseMolecular Therapy, 2009
- Dual mechanism of brain injury and novel treatment strategy in maple syrup urine diseaseBrain, 2008
- SUCCESSFUL THERAPY OF NIEMANN-PICK DISEASE BY IMPLANTATION OF HUMAN AMNIOTIC MEMBRANETransplantation, 1987